日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial

SURMOUNT-5试验结果显示，在肥胖或超重成人患者中，替泽帕肽与索玛鲁肽相比，可改善健康相关的生活质量。

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.70215
Shukla, Alpana P; Dunn, Julia P; Gomez Valderas, Elisa; Fraseur Brumm, Julia; Karanikas, Chrisanthi A; Hunter Gibble, Theresa
肥胖
代谢
发表日期：2026
文献求助 收藏

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

替泽帕肽在肥胖且无已知重大精神病理学患者中的精神安全性：SURMOUNT 研究的事后分析

期刊:
影响因子:
doi:10.1002/oby.70122
Wadden, Thomas A; Oquendo, Maria A; Kushner, Robert F; Cao, Dachuang; Karanikas, Chrisanthi A; Kechter, Afton; Murphy, Madhumita A
肥胖
代谢
发表日期：2026
文献求助 收藏

Urothelial Carcinoma With a Novel MET Exon 14 Skipping Alteration

具有新型MET外显子14跳跃突变的尿路上皮癌

期刊:
影响因子:
doi:10.21873/cdp.10517
Petropoulou, Evmorfia; Stavridi, Flora; Bili, Chrisanthi; Florentin, Lina; Kakavouli, Gesthimani; Spanakis, Nikolaos
肿瘤
MET
肿瘤免疫
发表日期：2026
文献求助 收藏

Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme

使用替拉帕肽维持血糖控制并持续减轻体重的时间：SURPASS 临床试验计划的事后分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16337
Bergman, Brandon K; Rosenstock, Julio; Garvey, W Timothy; Batterham, Rachel L; Chen, Yanyun; Liu, Minzhi; Sharma, Palash; Karanikas, Chrisanthi A; Thieu, Vivian T
发表日期：2025
文献求助 收藏

Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS

替拉帕肽治疗GADA阳性患者的HbA1c和体重均得到改善：SURPASS研究的事后分析

期刊:Journal of Clinical Endocrinology & Metabolism
影响因子:5.1
doi:10.1210/clinem/dgae372
Peters, Anne L; Buzzetti, Raffaella; Lee, Clare J; Pavo, Imre; Liu, Minzhi; Karanikas, Chrisanthi A; Paik, Jim S
ADA
发表日期：2025
文献求助 收藏

Seasonal Variation in Nutritional Value and Technical Quality of Lionfish (Pterois miles) from the Ionian and Aegean Seas

爱奥尼亚海和爱琴海狮子鱼（Pterois miles）营养价值和技术品质的季节性变化

期刊:Foods
影响因子:5.1
doi:10.3390/foods14132353
Kotsiri, Mado; Kogiannou, Dimitra; Nikoloudaki, Chrisanthi; Kleidas, Ioannis; Dogrammatzi, Aikaterini; Karachle, Paraskevi K; Grigorakis, Kriton
发表日期：2025
文献求助 收藏

Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide

在接受替拉帕肽治疗的 2 型糖尿病患者中，低血糖钳夹试验期间的低血糖反调节反应

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1627947
Pieber, Thomas R; Svehlikova, Eva; Urva, Shweta; Haupt, Axel; Zhou, Chunmei; Coskun, Tamer; Höller, Vera; Fluhr, Gabriele; Karanikas, Chrisanthi A; Milicevic, Zvonko; Pratt, Edward John
糖尿病
代谢
发表日期：2025
文献求助 收藏

Early-Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials

早发性肥胖与替泽帕肽治疗：SURMOUNT临床试验的事后分析

期刊:
影响因子:
doi:10.1002/oby.24348
Gourgari, Evgenia; Srivastava, Gitanjali; Kelly, Aaron S; Mojdami, Donna; Cao, Dachuang; Murphy, Madhumita A; Karanikas, Chrisanthi A; Lee, Clare J
肥胖
代谢
发表日期：2025
文献求助 收藏

Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program

根据生育阶段对接受替拉帕肽治疗的女性进行体重减轻情况分析：SURMOUNT 项目的一项事后分析

期刊:
影响因子:
doi:10.1002/oby.24254
Tchang, Beverly G; Mihai, Andreea Ciudin; Stefanski, Adam; García-Pérez, Luis-Emilio; Mojdami, Donna; Jouravskaya, Irina; Gurbuz, Sirel; Taylor, Rebecca; Karanikas, Chrisanthi A; Dunn, Julia P
发表日期：2025
文献求助 收藏

Aβ immunotherapy drives immune activation and cerebrovascular damage in a mouse model of Alzheimer’s Disease

Aβ免疫疗法在阿尔茨海默病小鼠模型中驱动免疫激活和脑血管损伤

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2022.101741
Zarogoulidis, Paul; Kosmidis, Christoforos; Perdikouri, Eleni-Isidora; Hohemforst-Schmidt, Wolfgang; Sardeli, Chrisanthi; Taylor, Xavier; Noristani, Harun; Fitzgerald, Griffin; Oluoch, Herold; Babb, Nick; McGathey, Tyler; Hole, Justin T; Lacor, Pascale; DeMattos, Ronald B; Wang, Yaming
阿尔茨海默症
神经科学
免疫/内分泌
发表日期：2024
文献求助 收藏